$IPX

Hannigan Todd purchased $1.9M of IPX

Hannigan Todd (Executive Chairman) purchased 525,000 shares of IPERIONX Ltd (IPX) at an average of $3.58 ($3.58–$3.59, $1.88M total) across 2 trades over 2026-07-10 to 2026-07-13.

Original reporting
SEC EDGAR · Hannigan Todd
Published Jul 13, 2026, 12:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 13, 2026, 12:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$IPX
Bullish
medium confidence
Mentioned
$IPX
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IPXBullishLow
01

Why it matters

The newest fact is the disclosed open-market purchase size, price range, and post-transaction holdings by the Executive Chairman.

02

Market read

Traders may monitor for sentiment follow-through, but the filing alone does not change fundamentals.

03

What to watch

No 10b5-1 plan is cited, but the article provides no context on prior insider activity, motivations, or whether the purchase was part of a broader pattern.

Relevance 7/10Novelty 4/10Timing: Filed on 2026-07-13 after trades dated 2026-07-10 to 2026-07-13.

Background

The article is an SEC Form 4 insider transaction disclosure for IPERIONX Ltd (IPX).

Company-level read

Ticker impact

$IPXBullishMedium confidence
Context

SEC Form 4 shows Executive Chairman Hannigan Todd bought 525,000 IPX shares for about $1.88M at $3.5786 to $3.5866.

Expected impact

Near-term impact likely limited; any effect is sentiment-driven and may fade without follow-on company news.

Evidence & confidence

The filing is primary-source and time-stamped, but it lacks new operational or financial disclosures, and there is no 10b5-1 plan stated.

Market effects

No sector-level implications disclosed; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Insider buying may reflect diversification, liquidity needs, or routine compensation-related activity rather than a strong forward-looking view.

Key entities

  • IPERIONX Ltd

    Company whose shares were purchased; subject of the Form 4 insider transaction.

  • Hannigan Todd

    Executive Chairman and reporting person who purchased shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$IPXMedAI 8/10

IperionX Raises $50 Million to Expand U.S. Titanium Production - 3DPrint.com

IperionX raised about $50 million via a public offering, selling 2.275 million shares at $21.98 each, to expand U.S. titanium manufacturing. The company plans to increase capacity in Virginia, continue its Tennessee Camden Titanium Project, and fund low-carbon titanium R&D, according to the company. Cantor Fitzgerald led, with Roth Capital Partners and B. Riley Securities co-managing.

$VODMed

EasyJet, Vodafone & Picton: Markets live

Apollo Global Management raised its easyJet (EZJ) cash offer to 715p per share, valuing the airline at £5.7bn, and easyJet’s board said it is minded to recommend. The bid is 25p higher than Castlelake’s. Other updates: MJ Gleeson (GLE) expects results in line but outlook uncertain; Impax (IPX) AUM rose to £23.3bn; Vodafone (VOD) gets e& stake sold to Xavier Niel; Schroder REIT (SREI) bid for Picton (PCTN); Hays (HAS) profit guidance; Johnson Service Group (JSG) shares fall.

$IPXHighAI 10/10

IperionX Shares Dive Following Capital Raise: The Details

IperionX (ASX:IPX) shares fell 14.14% to A$3.46 after the company priced an underwritten public offering of 2.275m ADS at US$21.98 each, raising about US$50m gross. Each ADS equals 10 ordinary shares, implying 22.75m new shares and over 22m-share dilution. Proceeds fund Virginia expansion, R&D, Camden-Titan, and general purposes.

$IPXMed

IperionX Announces Pricing of Public Offering of American Depositary Shares – LiveNews.co.nz

IperionX Limited (Nasdaq:IPX; ASX:IPX) priced an underwritten public offering of 2,275,000 ADSs at $21.98 per ADS, raising about $50 million in gross proceeds, before underwriting and offering expenses. Each ADS represents 10 ordinary shares. Proceeds will fund titanium technology commercialization, Virginia campus scale-up, Tennessee Camden-Titan development, and general corporate purposes; closing is expected July 9, 2026.